Category

Opioid Use Disorder

← All posts
Conditions

The Best Psychedelic for Addiction? Comparing Ibogaine, Psilocybin, Ketamine, Ayahuasca

There is no single best psychedelic for addiction, because the evidence is organized by which substance you are trying to stop. Psilocybin has the strongest controlled-trial...

August 11, 2026 · 10 min
Conditions

Addiction Psychedelic Therapy: What the Science Says About Breaking the Cycle

Early clinical research on addiction and psychedelic therapy is genuinely promising, with controlled trials showing meaningful reductions in heavy drinking and high abstinence rates in tobacco...

August 9, 2026 · 8 min
Conditions

Ibogaine for Opioid Addiction: What the Evidence and the Risks Actually Show

Ibogaine opioid addiction treatment can interrupt physical withdrawal and reduce cravings after a single session, an effect no approved medication produces. The evidence comes almost entirely...

August 8, 2026 · 10 min
Science & Research

Ayahuasca Addiction Treatment: What the Evidence Shows

Research on ayahuasca addiction treatment is both encouraging and genuinely limited. Observational studies and large international surveys report reduced alcohol, tobacco, and cocaine use following ceremonial...

August 7, 2026 · 10 min
Science & Research

Ibogaine Therapy: A Complete Guide to the Most Powerful and Risky Psychedelic

Ibogaine is a plant-derived psychedelic with real promise for interrupting opioid addiction and, more recently, for treating trauma, but it carries a risk of fatal heart...

August 6, 2026 · 10 min
Conditions

Ketamine Addiction Treatment: An Emerging Pathway for Alcoholism and Substance Use

Ketamine addiction treatment is supported by several small randomized trials showing improved abstinence in alcohol and cocaine use disorder, but only when the infusion is paired...

July 29, 2026 · 10 min
Conditions

Ibogaine Opioid Treatment Research: What 2025-2026 Studies Found

Ibogaine opioid treatment research has moved significantly forward in 2025 and 2026, with new clinical data, a landmark $50 million Texas state investment, and a federal...

April 28, 2026 · 9 min

Ready to take the next step?

Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.